Stock listing
Lang & Schwarz:A41A98 Verrica Pharmaceuticals Inc. Aktie
German listing (Lang & Schwarz) of Verrica Pharmaceuticals Inc. · home listing NASDAQ:VRCA
Follow Verrica Pharmaceuticals Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:VRCA
$3.21 USD -0.14 (-4.2%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:VRCA
- Day range
- $3.20 – $3.62 USDNov 2, 2026
- Volume
- 55,797 sharesNov 2, 2026
- Market cap
- $55.14M USDAt the close on Nov 2, 2026 · price × 17.18M shares outstanding
- 52-week range
- $3.20 – $9.82 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $327,150 USDMedian day 48,300 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:VRCA · Home | $3.21 USD | -0.14 (-4.2%) | 55,797 | $3.40 | $3.62 | $3.20 | $3.35 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:VRCA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.21 | -0.14 | -4.2% | $3.40 | $3.62 | $3.20 | 55,797 | |
| $3.35 | -0.07 | -2.0% | $3.42 | $3.47 | $3.25 | 31,486 | |
| $3.42 | -0.06 | -1.7% | $3.501 | $3.60 | $3.39 | 27,078 | |
| $3.48 | +0.01 | +0.3% | $3.45 | $3.565 | $3.39 | 22,176 | |
| $3.47 | +0.05 | +1.5% | $3.52 | $3.52 | $3.335 | 27,984 | |
| $3.42 | -0.11 | -3.1% | $3.55 | $3.68 | $3.39 | 21,890 | |
| $3.53 | -0.30 | -7.8% | $3.76 | $3.76 | $3.40 | 21,000 | |
| $3.83 | +0.20 | +5.5% | $3.50 | $4.17 | $3.50 | 109,900 | |
| $3.63 | +0.16 | +4.6% | $3.46 | $3.64 | $3.441 | 60,400 | |
| $3.47 | +0.03 | +0.9% | $3.44 | $3.56 | $3.30 | 77,200 | |
| $3.44 | -0.155 | -4.3% | $3.61 | $3.645 | $3.42 | 79,800 | |
| $3.595 | -0.185 | -4.9% | $3.85 | $3.95 | $3.48 | 116,500 | |
| $3.78 | -0.05 | -1.3% | $3.92 | $3.95 | $3.746 | 64,300 | |
| $3.83 | +0.25 | +7.0% | $3.54 | $3.92 | $3.50 | 54,000 | |
| $3.58 | -0.43 | -10.7% | $3.99 | $4.38 | $3.51 | 82,800 | |
| $4.01 | -0.10 | -2.4% | $4.20 | $4.20 | $4.00 | 48,100 | |
| $4.11 | -0.07 | -1.7% | $4.37 | $4.37 | $4.06 | 46,600 | |
| $4.18 | +0.04 | +1.0% | $4.14 | $4.29 | $4.05 | 37,200 | |
| $4.14 | -0.07 | -1.7% | $4.15 | $4.33 | $4.06 | 47,600 | |
| $4.21 | -0.10 | -2.3% | $4.36 | $4.41 | $4.17 | 40,600 | |
| $4.31 | -0.07 | -1.6% | $4.34 | $4.539 | $4.25 | 34,300 | |
| $4.38 | -0.135 | -3.0% | $4.56 | $4.843 | $4.37 | 44,100 | |
| $4.515 | -0.28 | -5.8% | $4.85 | $4.85 | $4.515 | 54,500 | |
| $4.795 | +0.335 | +7.5% | $4.51 | $5.04 | $4.51 | 51,000 | |
| $4.46 | -0.14 | -3.0% | $4.67 | $4.67 | $4.453 | 3,700 | |
| $4.60 | +0.23 | +5.3% | $4.33 | $4.63 | $4.32 | 33,000 | |
| $4.37 | +0.01 | +0.2% | $4.39 | $4.50 | $4.36 | 72,800 | |
| $4.36 | -0.26 | -5.6% | $4.62 | $4.642 | $4.355 | 40,900 | |
| $4.62 | -0.10 | -2.1% | $4.67 | $4.78 | $4.55 | 41,300 | |
| $4.72 | +0.23 | +5.1% | $4.50 | $4.90 | $4.50 | 65,100 | |
| $4.49 | +0.04 | +0.9% | $4.55 | $4.635 | $4.40 | 29,600 | |
| $4.45 | -0.20 | -4.3% | $4.61 | $4.74 | $4.45 | 113,500 | |
| $4.65 | +0.12 | +2.6% | $4.70 | $4.79 | $4.57 | 41,300 | |
| $4.53 | -0.05 | -1.1% | $4.66 | $4.695 | $4.53 | 48,300 | |
| $4.58 | -0.20 | -4.2% | $4.75 | $4.77 | $4.514 | 46,400 | |
| $4.78 | -0.13 | -2.6% | $4.91 | $5.06 | $4.70 | 43,100 | |
| $4.91 | -0.04 | -0.8% | $4.99 | $5.03 | $4.80 | 41,900 | |
| $4.95 | -0.11 | -2.2% | $5.06 | $5.25 | $4.86 | 56,800 | |
| $5.06 | -0.20 | -3.8% | $5.25 | $5.40 | $5.05 | 47,800 | |
| $5.26 | -0.04 | -0.8% | $5.30 | $5.414 | $5.04 | 112,200 | |
| $5.30 | -0.06 | -1.1% | $5.28 | $5.525 | $5.25 | 12,200 | |
| $5.36 | -0.03 | -0.6% | $5.48 | $5.63 | $5.27 | 55,400 | |
| $5.39 | +0.15 | +2.9% | $5.32 | $5.56 | $5.284 | 31,100 | |
| $5.24 | -0.22 | -4.0% | $5.36 | $5.56 | $5.22 | 43,500 | |
| $5.46 | -0.23 | -4.0% | $5.70 | $5.831 | $5.295 | 106,400 | |
| $5.69 | +0.62 | +12.2% | $5.12 | $5.86 | $5.00 | 350,800 | |
| $5.07 | +0.16 | +3.3% | $5.01 | $5.65 | $4.90 | 533,600 | |
| $4.91 | -0.03 | -0.6% | $4.86 | $5.055 | $4.84 | 27,700 | |
| $4.94 | +0.07 | +1.4% | $4.90 | $4.99 | $4.75 | 54,900 | |
| $4.87 | +0.05 | +1.0% | $4.81 | $4.95 | $4.61 | 67,900 | |
| $4.82 | -0.04 | -0.8% | $4.90 | $4.99 | $4.64 | 78,800 | |
| $4.86 | -0.13 | -2.6% | $4.99 | $5.181 | $4.83 | 138,100 | |
| $4.99 | +0.31 | +6.6% | $5.22 | $5.22 | $4.77 | 169,800 | |
| $4.68 | -0.21 | -4.3% | $4.90 | $5.00 | $4.68 | 50,300 | |
| $4.89 | -0.08 | -1.6% | $5.00 | $5.15 | $4.765 | 179,700 | |
| $4.97 | +0.11 | +2.3% | $4.89 | $5.098 | $4.78 | 59,600 | |
| $4.86 | -0.23 | -4.5% | $5.11 | $5.351 | $4.77 | 56,300 | |
| $5.09 | -0.13 | -2.5% | $5.19 | $5.25 | $5.05 | 26,900 | |
| $5.22 | +0.10 | +2.0% | $5.21 | $5.85 | $5.12 | 82,200 | |
| $5.12 | +0.04 | +0.8% | $5.18 | $5.34 | $5.06 | 22,300 | |
| $5.08 | -0.28 | -5.2% | $5.31 | $5.50 | $4.70 | 126,300 | |
| $5.36 | -0.15 | -2.7% | $5.58 | $5.87 | $5.26 | 85,200 | |
| $5.51 | +0.10 | +1.8% | $5.48 | $5.61 | $5.405 | 12,000 | |
| $5.41 | +0.16 | +3.0% | $5.23 | $5.51 | $5.20 | 28,400 | |
| $5.25 | +0.03 | +0.6% | $5.22 | $5.54 | $5.08 | 32,400 |
- Ticker
- Lang & Schwarz:A41A98
- Asset type
- Stock
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Oct 22, 2026
Verrica Pharmaceuticals Announces Achievement of Milestones Unlocking Access to the Full $27.5 Million of Non-Dilutive Growth Capital Under Credit Facility
Latest earnings call · Aug 6, 2026
Verrica Pharmaceuticals (NASDAQ:VRCA) Q2 2026 Earnings Call
Replay and transcript
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 22 slides
Calls
Replays
Verrica Pharmaceuticals (NASDAQ:VRCA) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 4:30 PM ET
Watch TranscriptVerrica Pharmaceuticals (NASDAQ:VRCA) Q1 2026 Earnings Call
Tue, May 12, 2026 · 4:30 PM ET
Watch TranscriptVerrica Pharmaceuticals (NASDAQ:VRCA) Q4 2025 Earnings Call
Wed, Mar 11, 2026 · 8:15 AM ET
Watch Transcript
Latest news
Verrica Pharmaceuticals Announces Achievement of Milestones Unlocking Access to the Full $27.5 Million of Non-Dilutive Growth Capital Under Credit Facility
Oct 22, 2026
Closed $3.83 (+5.5%) on Oct 22, 2026
Verrica Pharmaceuticals to Present New YCANTH® Data Analysis at Two Upcoming Dermatology Conferences
Sep 30, 2026
Closed $4.80 (+7.5%) on Sep 30, 2026
Verrica Pharmaceuticals to Present YCANTH® and VP-315 Data at Two Upcoming Dermatology Conferences
Sep 10, 2026
Closed $4.95 (-2.2%) on Sep 10, 2026
Verrica Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Sep 8, 2026
Closed $5.26 (-0.8%) on Sep 8, 2026
Verrica Pharmaceuticals Announces Completion of Enrollment in First Pivotal Phase 3 Trial (COVE-2) Evaluating YCANTH® for the Treatment of Common Warts, with Topline Data Expected Q1 2027
Aug 27, 2026
Closed $5.07 (+3.3%) on Aug 27, 2026
Verrica Pharmaceuticals Reports Second Quarter 2026 Financial Results
Aug 6, 2026
Closed $5.08 (-5.2%) on Aug 7, 2026
Verrica Pharmaceuticals Closes Credit Facility For Up To $27.5 Million in Non-Dilutive Growth Capital
Aug 6, 2026
Closed $5.08 (-5.2%) on Aug 7, 2026
Verrica Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026
Jul 30, 2026
Closed $5.26 (+1.5%) on Jul 30, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 22 slides · September 2026
Investor Presentation (August 2024)
Investor deck · 59 slides · August 2024
Investor Presentation (May 2024)
Investor deck · 48 slides · May 2024
Investor Presentation (January 2024)
Investor deck · 51 slides · January 2024
Verrica Pharmaceuticals Inc. on 6ix
- News releases
- 26 in the last 12 months · 141 in all · newest Oct 22, 2026 · oldest 2019
- Calls
- 11 calls with a replay · 11 with a transcript · latest Aug 6, 2026
- Decks
- 24 decks · latest September 2026
Where Verrica Pharmaceuticals Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:VRCA · Home listing | NASDAQ | United States | USD |
| Lang & Schwarz:A41A98 · This page | Lang & Schwarz | Germany | EUR |
| Tradegate:1NE0 | Tradegate | Germany | EUR |
| BOATS:VRCA | BOATS | United States | USD |
| gettex:1NE0 | gettex | Germany | EUR |
| LS Exchange:A41A98 | LS Exchange | Germany | EUR |
| Frankfurt:1NE0 | Frankfurt | Germany | EUR |
| Stuttgart:1NE0 | Stuttgart | Germany | EUR |
| Munich:1NE0 | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Verrica Pharmaceuticals Inc.